Other OTC Pharmaceuticals (Pharmacies) - Cuba

  • Cuba
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$166.20m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.83%, resulting in a market volume of US$171.80m by 2028.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$14.88 are generated in 2024.

Key regions: United Kingdom, Canada, France, Europe, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Cuba is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trajectory. Customer preferences in the Other OTC Pharmaceuticals (Pharmacies) market in Cuba are shifting towards a greater demand for over-the-counter medications. This can be attributed to several factors, including the convenience and accessibility of these products. Customers are increasingly looking for quick and easy solutions to common health issues, and over-the-counter medications provide a convenient option. Additionally, the affordability of these products compared to prescription medications makes them an attractive choice for many customers. Trends in the market are also driving the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Cuba. One major trend is the increasing focus on preventive healthcare. Customers are becoming more proactive in managing their health and are seeking out products that can help them prevent illness and maintain overall well-being. This trend is particularly evident in the growing demand for vitamins, supplements, and other preventive healthcare products. Another trend in the market is the rising popularity of natural and herbal remedies. Customers are increasingly seeking out alternative treatments and are turning to natural products for their health needs. This trend is driven by a growing awareness of the potential side effects and risks associated with traditional pharmaceuticals. As a result, pharmacies in Cuba are expanding their offerings to include a wider range of natural and herbal products to meet customer demand. Local special circumstances also play a role in the development of the Other OTC Pharmaceuticals (Pharmacies) market in Cuba. The country's healthcare system is focused on providing universal access to healthcare services, including medications. As a result, pharmacies play a crucial role in delivering healthcare services to the population. This has created a strong demand for over-the-counter medications, as they are often the first line of treatment for many common ailments. Underlying macroeconomic factors are also contributing to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Cuba. The country's economy has been steadily improving, leading to an increase in disposable income among the population. This has allowed more customers to afford over-the-counter medications and has fueled the demand for these products. Additionally, the government's efforts to promote the development of the healthcare sector have created a favorable business environment for pharmacies, further driving market growth. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Cuba is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trajectory. As the demand for over-the-counter medications continues to rise, pharmacies in Cuba are well-positioned to meet the needs of the population and drive further market expansion.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)